Author: Devin Weiss

American Greetings Corp.’s(AM) MACD indicator has crossed over to bearish territory with a reading of -0.0192. The Zacks #4 Rank (“Sell”) stock has slipped more than 2% to $6.8 in afternoon trade. Analysts have...

We reiterate our Hold rating for China Telecom (CHA), the largest fixed-line service provider in China. The company entered the Chinese mobile telephony market through the acquisition of CDMA business and network assets from...

Shares of Blackstone Group (BX) gained strength on Friday morning on reports that China Investment Corp (CIC) was mulling injecting as much as $500 million in the hedge fund. Citing people close to the matter, the Wall...

CarMax Inc. (KMX) reported first-quarter adjusted earnings that easily topped Wall Street expectations, despite lackluster sales. Shares of this Zacks #1 Rank (“Strong Buy”) company jumped nearly 14% in response....

The Moody’s/Real National All Property Index dropped 1.7% in March compared to February of this year. In addition, the index is about 21% lower than a year ago and about 20% lower than two years ago. This index tracks the...

Today, the BLS released the unemployment rates by state for May. It shows that the rise in unemployment has been widespread and few regions have been spared.There are now 14 with double-digit unemployment (27.4%) vs. none a year...

Teekay Tankers Ltd. (TNK) said that it would sell 7 million shares of common stock in a public offering priced at $9.80 per share, which is a 7.6% discount to TNK’s Thursday close of $10.61. Through the proceeds, the...

Aradigm Corp (ARDM). is a difficult company to value. We like the product pipeline, specifically the inhaled Cipro product (ILCH) for BE and CF, but more visibility is needed before we can recommend investment in the name.Plus,...

With the expected spin-off of its mat-supported jackup fleet in the Gulf of Mexico in the next few months, Pride International (PDE) will become a pure-play deepwater driller. The company plans to complete the spin-off of...

AMAG Pharmaceuticals Awaits Final FDA Decision by Month-End The US FDA will make a final decision on AMAG Pharmaceuticals Inc.’s (AMAG) anti-anemia drug Feraheme (ferumoxytol) on June 29, 2009.After a series of delays,...